Fevertree Drinks' recent strategic partnership with Molson Coors is set to accelerate its growth in the U.S. See why FQVTF ...

The issues that caused these higher cost of goods sold are transitory, and Fevertree management are doing the right things.

The agreement has been structured as a licence deal, with Fever-Tree receiving royalty fees based on its share of the profit generated in the US (with minimum payments guaranteed for five years).

Berenberg raised the firm’s price target on Fevertree Drinks (FQVTF) to 860 GBp from 700 GBp and keeps a Hold rating on the shares.Maximize ...

Morgan Stanley analyst Rashad Kawan lowered the firm’s price target on Fevertree Drinks (FQVTF) to 725 GBp from 800 GBp and keeps an Equal ...

Berenberg hiked its target price for tonic maker Fever-Tree from 700.0p to 860.0p on the back of the tonic maker's ...

TAP expands its non-alcoholic portfolio with a strategic partnership and investment in Fever-Tree, targeting growth in the ...

Could selling shares at £6.93 before buying them back at £7.78 could be a brilliant move for a UK company with US growth ...

Fever-Tree is already the largest tonic and ginger beer brand in the US by value: but the brand believes there’s still huge ...

The London-listed mixer-maker said Molson Coors would acquire an 8.5% shareholding in Fevertree.

Shares of Fever-Tree Drinks surged on Thursday as it announced that Coors Light maker Molson Coors will buy an 8.5% stake in ...

US brewing giant Molson Coors is set to acquire an 8.5% stake in Fevertree for £71m ($88.29m) in cash, as a part of a ...